Halozyme Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US40637H1095
USD
78.42
1.94 (2.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryHalozyme Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
2.54%
-0.51%
1W
7.68%
-1.37%
1M
11.53%
0.35%
YTD
16.52%
0.54%
1Y
38.14%
13.99%
3Y
48.95%
66.39%
5Y
62.6%
77.77%
10Y
62.6%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
15.24%
0%
15.24%
6 Months
30.72%
0%
30.72%
1 Year
38.14%
0%
38.14%
2 Years
132.84%
0%
132.84%
3 Years
48.95%
0%
48.95%
4 Years
132.7%
0%
132.7%
5 Years
62.6%
0%
62.6%

Halozyme Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary